F-Prime Capital Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 32
- Investments
- 360
- Portfolio
- 144
- Exits
- 102
F-Prime Capital General Information
Description
Founded in 1969, F-Prime Capital is a global venture capital firm based in Cambridge, Massachusetts. The firm invests in the healthcare and technology.
Contact Information
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Primary Office
- 1 Main Street
- 13th Floor
- Cambridge, MA 02142
- United States
+1 (617) 000-0000
F-Prime Capital Investments (360)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Atalanta Therapeutics | 11-Jan-2021 | Early Stage VC | 00000 | Biotechnology | Startup | 000000 00000000 00.0 |
| 0 000000 | 06-Jan-2021 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | |
| 0000000 | 07-Dec-2020 | 00000 00000 | 000.00 | Managed Care | Generating Revenue | 00000000 000 |
| 000000000 | 01-Dec-2020 | 00000 00000 | 000.00 | Financial Software | Generating Revenue | |
| 000000 | 30-Nov-2020 | 0000 00000 | 00.000 | Financial Software | Generating Revenue | |
| 0000000 | 27-Oct-2020 | 00000 00000 | 000.00 | Business/Productivity Software | Generating Revenue | |
| 00000000 | 13-Oct-2020 | 00000 00000 | 0000 | Financial Software | Generating Revenue | 00000 00000 00 |
| 000000 0000000 | 25-Sep-2020 | 00000 00000 | 0000 | Software Development Applications | Generating Revenue | |
| Neurogeneus | 16-Sep-2020 | Seed Round | 000.00 | Other Commercial Products | Stealth | |
| Carrot (Other Healthcare Services) | 18-Aug-2020 | Later Stage VC | 0000 | Other Healthcare Services | Generating Revenue |
F-Prime Capital Exits (99)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| TradeBlock | 05-Jan-2021 | Merger/Acquisition | |
| 0000 000000000000 | 01-Oct-2020 | 000000 0000000000 | 00000 |
| 000000000 | 01-Sep-2020 | 000000000000000000 | 00000 |
| 0000000 | 12-Aug-2020 | 0000000000 | |
| 000000000 00000000 | 07-Aug-2020 | 000 | 0000 |
| 000000000 | 29-Jul-2020 | 000 | 00000 |
| 00000 | 09-Jul-2020 | 000000000000000000 | |
| 0000000 0000000000 | 12-Jun-2020 | 000 | 00000 |
| Beam Therapeutics | 05-Feb-2020 | IPO | 00000 |
| Denali Therapeutics | 28-Jan-2020 | Secondary Transaction - Open Market | 00000 |
F-Prime Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialF-Prime Capital Team (88)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Stephen Knight MD | President & Managing Partner | 00 | 0 | 00 | Cambridge, MA |
| Stacie Weninger Ph.D | President, FBRI | 0 | 0 | Cambridge, MA | |
| Mary Pendergast | Partner & Chief Operating Officer | Cambridge, MA | |||
| Adrienne Harris JD | Venture Partner | 0 | San Francisco, CA | ||
| Amber Cai Ph.D | Venture Partner | China |
F-Prime Capital Co-Investors (531)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Eight Roads | 58 | 0 | 00 |
|
|
| ARCH Venture Partners | 0 | 0 | 0 |
|
|
| Maverick Ventures | 0 | 0 |
|
|
|
| GV | 0 | 0 |
|
|
|
| OrbiMed | 0 | 0 | 0 |
|
|